Sponsor Pipeline

LB Pharmaceuticals Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
3
Recruiting
2
Phase 3
2
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-28 NCT07369154
52-week Open Label Safety-Tolerability Study		 Recruitment opened
Active Trials by Phase
Phase 3
2
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07363577 Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia Schizophrenia Recruiting
NCT07369154 52-week Open Label Safety-Tolerability Study Schizophrenia Recruiting
Phase 2
NCT07494305 Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult… Bipolar I Disorder Recruiting
Disease Areas
Schizophrenia (2) Bipolar Disorder (1)
Get alerts when LB Pharmaceuticals Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free